subject

This 10% capital gains tax applies to natural persons with a tax residence in Belgium and non-profit associations and foundations with the exception of those that are being recognised as tax deductible for gifts. Natural persons with a tax residence outside Belgium and legal entities (such as companies that are subject to corporate income tax) are exempt from capital gains tax.

When a life insurance policy is subject to capital gains tax, the tax is due as soon as a capital gain is realized upon surrender or upon the payment of the death benefit at the end of the policy term.If the policy is paid out following the death of the insured, the beneficiaries under the death benefit clause do not have to pay any capital gains tax on the realized gains. It goes without saying, however, that inheritance tax may still be due in accordance with applicable law.

A 10% tax applies to capital gains realized upon surrender or maturity of certain life insurance policies. More specifically, the following policies are affected: Branch 21 savings insurance: for which the eight-year term has expired with death benefit coverage of at least 130% of the premiums paid Branch 23 investment insurance policies Investment insurance policies combining Branch 21 and Branch 23, also known as Branch 44. If a Branch 21 or 26 policy (capitalization transaction) is subject

anti- money laundering and anti-terrorism procedures, if required by law or certain guidelines or regulations of a competent supervisory authority. 4 HOW WE USE YOUR PERSONAL DATA LEGALLY We may use your personal data on various legal bases, subject... obligation or with regard to the legitimate interest that justifies such transfer. In accordance with the relevant legislation, the parties will only process your personal data on our instructions and are subject to a duty of confidentiality. Third

, Monument may be subject to regulatory censure or fines or both as a consequence of failing to have appropriate systems and controls in place to provide adequate management of any conflict of interest. 1.1.5 Conflicts of interest may arise in the... their own personal interests with or against the interests of the Company. Such behaviour will not be tolerated and any staff member who acts outside the agreed-upon values may be subject to disciplinary action. 1.2.3 This Policy is designed to ensure

regulatory requirements continue to evolve, this document is subject to modification allowing MAB to continue to apply this requirements. 3 Monument Group: PUBLIC ▪ Our values 2. ESG Statement ▪ Responsible Corporate Governance ▪ Governance Structure

between equity in the financial statements and the excess of assets over liabilities for solvency purposes......................................................................................... 79 E.1 (d) Basic own fund item subject to the

, typically with guarantees. Monument Re is a Class E reinsurer and holding company of other European insurance entities. It is subject to Group Supervision by the BMA through Solvency II Equivalence attained on a permanent basis from the European Commission... also three further transactions that remained subject to regulatory approval at 31 December 2021 (and which are not reflected in the financials presented here). Monument Assurance Belgium N.V. (“MAB”) Monument Re acquired ABN AMRO Life Capital Belgium

Re is a Class E reinsurer and holding company of other European insurance entities. It is subject to Group Supervision by the BMA through Solvency II Equivalence attained on a permanent basis from the European Commission. Monument Re has an

liabilities, typically with guarantees. Monument Re is a Class E reinsurer and holding company of other European insurance entities. It is subject to Supervision by the BMA through Solvency II Equivalence attained on a permanent basis from the European

.......................................................................................... 77 E.1 (d) Basic own fund item subject to the transitional arrangements ........................................ 78 E.1 (e) Ancillary Own Funds